BridgeBio Pharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $919.3M
Liabilities Breakdown FY2024
Total Liabilities: $2.38B
Asset Breakdown
Total Assets: $919.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $681.1M | 74.1% |
| Accounts Receivable | $4.7M | 0.5% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $7.0M | 0.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $23.9M | 2.6% |
| Other Assets | $202.6M | 22.0% |
Liabilities Breakdown
Total Liabilities: $2.38B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.6M | 0.4% |
| Long-Term Debt | $437.3M | 18.4% |
| Other Liabilities | $1.93B | 81.2% |